Works matching DE "MONOCLONAL antibodies"
Results: 5000
Efficacy and Safety of GR1802 in Patients With Moderate‐to‐Severe Atopic Dermatitis: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Phase 2 Trial.
- Published in:
- Dermatologic Therapy, 2025, v. 2025, n. 1, p. 1, doi. 10.1155/dth/6903760
- By:
- Publication type:
- Article
Efficacy and continuability of 675 mg fremanezumab administration over 2 years.
- Published in:
- Journal of Headache & Pain, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s10194-025-01994-5
- By:
- Publication type:
- Article
Advancing treatments for transthyretin amyloid cardiomyopathy: Innovations in RNA silencing, gene editing, TTR stabilization, and degradation.
- Published in:
- Polish Heart Journal / Kardiologia Polska, 2025, v. 83, n. 2, p. 120
- By:
- Publication type:
- Article
Ebronucimab: First Approval: Ebronucimab: First Approval: H. A. Blair.
- Published in:
- Drugs, 2025, v. 85, n. 3, p. 437, doi. 10.1007/s40265-025-02146-4
- By:
- Publication type:
- Article
The Expanding Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Armamentarium: The Expanding AAV Armamentarium: D. P. McGovern et al.
- Published in:
- Drugs, 2025, v. 85, n. 3, p. 325, doi. 10.1007/s40265-024-02143-z
- By:
- Publication type:
- Article
Early clinical experience with a monoclonal antibody against the calcitonin gene-related peptide receptor in adolescents with migraine: A case series.
- Published in:
- Proceedings of Singapore Healthcare, 2020, v. 29, n. 3, p. 212, doi. 10.1177/2010105820935465
- By:
- Publication type:
- Article
Birth-dose hepatitis B vaccine and bronchopulmonary dysplasia risks in preterm infants.
- Published in:
- 2025
- By:
- Publication type:
- Editorial
Unexplored side effects of eculizumab in adolescents with atypical hemolytic uremic syndrome: the need for further investigation.
- Published in:
- 2025
- By:
- Publication type:
- Letter
Bone impairment in atypical hemolytic and uremic syndrome treated by long-term eculizumab.
- Published in:
- Pediatric Nephrology, 2025, v. 40, n. 4, p. 961, doi. 10.1007/s00467-024-06564-6
- By:
- Publication type:
- Article
Nearly 80% of infants born during 2023-2024 RSV season received RSV protection.
- Published in:
- Contemporary Pediatrics, 2025, v. 41, n. 2, p. 17
- By:
- Publication type:
- Article
Deep learning-based design and experimental validation of a medicine-like human antibody library.
- Published in:
- Briefings in Bioinformatics, 2025, v. 26, n. 1, p. 1, doi. 10.1093/bib/bbaf023
- By:
- Publication type:
- Article
Immunochemical Characteristics and Functional Activity of Monoclonal Antibodies Obtained to the Recombinant Form of Pneumolysin.
- Published in:
- Bulletin of Experimental Biology & Medicine, 2025, v. 178, n. 3, p. 346, doi. 10.1007/s10517-025-06334-w
- By:
- Publication type:
- Article
Minimal Residual Disease Significance in Multiple Myeloma Patients Treated with Anti-CD38 Monoclonal Antibodies.
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 2, p. 159, doi. 10.3390/ph18020159
- By:
- Publication type:
- Article
Monoclonal Antibodies in Relapsed-Refractory Multiple Myeloma.
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 2, p. 145, doi. 10.3390/ph18020145
- By:
- Publication type:
- Article
Real-World Lessons with Fremanezumab as the Third Available CGRP Monoclonal Antibody in a Third-Level Hospital: Focus on the Factors Predicting Response.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1054, doi. 10.3390/jcm14041054
- By:
- Publication type:
- Article
Clearing MRD positivity with blinatumomab in pediatric B-cell acute lymphoblastic leukemia: insights from droplet digital PCR and flow cytometry.
- Published in:
- Annals of Hematology, 2025, v. 104, n. 1, p. 559, doi. 10.1007/s00277-024-06126-8
- By:
- Publication type:
- Article
Six-year follow-up of phase II study exploring chemo-free treatment association with idelalisib and obinutuzumab in symptomatic relapsed/ refractory patients with Waldenström's macroglobulinemia.
- Published in:
- Annals of Hematology, 2025, v. 104, n. 1, p. 685, doi. 10.1007/s00277-024-06076-1
- By:
- Publication type:
- Article
Evidence-Based Recommendations on the Use of Immunotherapies and Monoclonal Antibodies in the Treatment of Male Reproductive Cancers.
- Published in:
- Current Oncology, 2025, v. 32, n. 2, p. 108, doi. 10.3390/curroncol32020108
- By:
- Publication type:
- Article
Anti-Spike Monoclonal Antibody Monotherapies and Immune Escape Risk Minimization Strategies.
- Published in:
- 2025
- By:
- Publication type:
- Letter to the Editor
Microbial Transglutaminase—The Food Additive, a Potential Inducing Factor in Primary Biliary Cholangitis.
- Published in:
- Molecules, 2025, v. 30, n. 4, p. 762, doi. 10.3390/molecules30040762
- By:
- Publication type:
- Article
Cervical cancer treatment and nursing considerations: Best practices for effective care.
- Published in:
- Canadian Oncology Nursing Journal, 2025, v. 35, n. 1, p. 244
- By:
- Publication type:
- Article
Virology Applications to the COVID-19 Pandemic.
- Published in:
- Life (2075-1729), 2025, v. 15, n. 2, p. 247, doi. 10.3390/life15020247
- By:
- Publication type:
- Article
Severe Asthma in School-Age Children: An Updated Appraisal on Biological Options and Challenges in This Age Group.
- Published in:
- Children, 2025, v. 12, n. 2, p. 167, doi. 10.3390/children12020167
- By:
- Publication type:
- Article
Tailoring Biologic Therapies for Pediatric Severe Asthma: A Comprehensive Approach.
- Published in:
- Children, 2025, v. 12, n. 2, p. 140, doi. 10.3390/children12020140
- By:
- Publication type:
- Article
Single-Chain Variable Fragments: Targeting Snake Venom Phospholipase A 2 and Serine Protease.
- Published in:
- Toxins, 2025, v. 17, n. 2, p. 55, doi. 10.3390/toxins17020055
- By:
- Publication type:
- Article
Examining the association of immunosuppressants and wound healing: a narrative review.
- Published in:
- World Council of Enterostomal Therapists Journal, 2024, v. 44, n. 3, p. 12, doi. 10.33235/wcet.44.3.12-19
- By:
- Publication type:
- Article
Atopic Dermatitis: clinical aspects and treatments.
- Published in:
- World Council of Enterostomal Therapists Journal, 2024, v. 44, n. 2, p. 29, doi. 10.33235/wcet.44.2.29-36
- By:
- Publication type:
- Article
Examining the association of immunosuppressants and wound healing: a narrative review.
- Published in:
- World Council of Enterostomal Therapists Journal, 2023, v. 43, n. 4, p. 32, doi. 10.33235/wcet.43.4.32-39
- Publication type:
- Article
Current and Emerging Strategies for Prediction and Diagnosis of Prelabour Rupture of the Membranes: A Narrative Review.
- Published in:
- Malaysian Journal of Medical Sciences, 2021, v. 28, n. 3, p. 5, doi. 10.21315/mjms2021.28.3.2
- By:
- Publication type:
- Article
Purification of an IgA Monoclonal Antibody Specific for the Acr Protein of Mycobacterium tuberculosis by Immunoaffinity Chromatography.
- Published in:
- Malaysian Journal of Medical Sciences, 2013, v. 20, n. 5, p. 16
- By:
- Publication type:
- Article
IMMUNOHISTOCHEMICAL STAINS (CARCINOEMBRYONIC ANTIGEN, VIMENTIN AND OESTROGEN RECEPTOR) IN THE DIAGNOSIS OF PRIMARY ENDOMETRIAL AND ENDOCERVICAL ADENOCARCINOMA.
- Published in:
- Malaysian Journal of Medical Sciences, 2006, v. 13, p. 210
- By:
- Publication type:
- Article
Long lasting remission by rituximab in a patient with primary cold agglutinin autoimmune haemolytic anaemia.
- Published in:
- 2011
- By:
- Publication type:
- Report
Adis summary of research: Lebrikizumab improves quality of life and patient-reported symptoms of anxiety and depression in patients with moderate-to-severe atopic dermatitis: Lebrikizumab improves quality of life: H. A. Blair.
- Published in:
- Drugs & Therapy Perspectives, 2025, v. 41, n. 2, p. 45, doi. 10.1007/s40267-024-01132-2
- By:
- Publication type:
- Article
Mirikizumab in moderately to severely active ulcerative colitis: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 11, p. 433, doi. 10.1007/s40267-024-01114-4
- By:
- Publication type:
- Article
Lecanemab in Alzheimer's disease: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 10, p. 393, doi. 10.1007/s40267-024-01108-2
- By:
- Publication type:
- Article
Correction to: Several more myasthenia gravis therapy options now available.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Nirsevimab in the prevention of respiratory syncytial virus lower respiratory tract disease: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 12, p. 413, doi. 10.1007/s40267-023-01039-4
- By:
- Publication type:
- Article
The PHASTER Study: Economic and Organizational Impact of Subcutaneous (SC) Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Treatment of HER2+ Breast Cancer Patients.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 12, p. 432, doi. 10.1007/s40267-023-01038-5
- By:
- Publication type:
- Article
Spesolimab in generalised pustular psoriasis flares: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 12, p. 404, doi. 10.1007/s40267-023-01034-9
- By:
- Publication type:
- Article
Tezepelumab in severe asthma: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 12, p. 393, doi. 10.1007/s40267-023-01033-w
- By:
- Publication type:
- Article
Ublituximab in relapsing forms of multiple sclerosis: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 11, p. 365, doi. 10.1007/s40267-023-01030-z
- By:
- Publication type:
- Article
Targeting toxic forms of α-synuclein with immunotherapy could alter the progression of Parkinson's disease.
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 11, p. 467, doi. 10.1007/s40267-022-00950-6
- By:
- Publication type:
- Article
Aducanumab: a review of the first approved amyloid-targeting antibody for Alzheimer's disease.
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 10, p. 443, doi. 10.1007/s40267-022-00944-4
- By:
- Publication type:
- Article
Tisotumab vedotin-tftv in previously treated recurrent or metastatic cervical cancer: a profile of its use in the USA.
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 9, p. 382, doi. 10.1007/s40267-022-00939-1
- By:
- Publication type:
- Article
Anifrolumab in systemic lupus erythematosus: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 7, p. 293, doi. 10.1007/s40267-022-00925-7
- By:
- Publication type:
- Article
Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma: a profile of its use in the USA.
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 6, p. 261, doi. 10.1007/s40267-022-00922-w
- By:
- Publication type:
- Article
DECODE enables high-throughput mapping of antibody epitopes at single amino acid resolution.
- Published in:
- PLoS Biology, 2025, v. 23, n. 1, p. 1, doi. 10.1371/journal.pbio.3002707
- By:
- Publication type:
- Article
Cloning, Monoclonal Antibody Production, and Bodily Distribution Pattern of a Bovine Lipocalin.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2012, v. 76, n. 4, p. 712, doi. 10.1271/bbb.110840
- By:
- Publication type:
- Article
Development of an Enzyme-Linked Immunosorbent Assay System for the Determination of Asymmetric Dimethylarginine Using a Specific Monoclonal Antibody.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2012, v. 76, n. 2, p. 400, doi. 10.1271/bbb.110727
- By:
- Publication type:
- Article
Immunochemical Detection of Food-Derived Polyphenols in the Aorta: Macrophages as a Major Target Underlying the Anti-Atherosclerotic Activity of Polyphenols.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2011, v. 75, n. 4, p. 609, doi. 10.1271/bbb.100785
- By:
- Publication type:
- Article